Image-guided Adaptive Brachytherapy for Cervix Carcinoma

Clinical Oncology

Volumn 20, Issue 6, 2008, Pages 426-432

  Potter R ^a   Fidarova, E ^a   Kirisits, C ^a   Dimopoulos, J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Brachytherapy; cervix cancer; computed tomography; magnetic resonance imaging

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTERVENTIONAL RADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA;

BRACHYTHERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 46149116302     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.04.011     Document Type: Article

References (52)

1. Gerbaulet A., Pötter R., and Haie-Meder C. Cervix cancer. In: Gerbaulet A., Pötter R., and Mazeron J.J. (Eds). The GEC ESTRO handbook of brachytherapy (2002), ESTRO, Brussels 301-363
2. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
3. Green J., Kirwan J., Tierney J., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 20 3 (2005) CD 002225
4. ICRU Report 38. Dose and volume specification for reporting intracavitary therapy in gynaecology (1985), International Commission on Radiation Units and Measurements, Bethesda
5. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
6. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): concepts and terms in 3D image based treatment planning in cervix cancer brachytherapy: aspects of 3D imaging, radiation physics, radiobiology, and 3D dose volume parameters. Radiother Oncol 78 (2006) 67-77
7. Chajon E., Dumas I., Touleimat M., et al. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. Int J Radiat Oncol Biol Phys 69 (2007) 955-961
8. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys, in press. doi:10.1016/j.ijrobp.2007.10.032.
9. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol, in press. doi:10.1016/j.radonc.2007.10.026.
10. Boss E., Barentsz J., Massugen L., et al. The role of MR imaging in invasive cervical carcinoma. Eur Radiol 10 (2000) 256-270
11. Viswanathan A.N., Dimopoulos J., Kirisits C., Berger D., and Pötter R. CT- versus MRI-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 68 (2007) 491-498
12. Kaur H., Silverman P.M., Iyer R.B., Verschraegen C.F., Eifel P.J., and Charnsangavej C. Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol 180 (2003) 1621-1631
13. Sala E., Wakely S., Senior E., and Lomas D. MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 188 (2007) 1577-1587
14. Hricak H., Lacey C.G., Sandles L.G., Chang Y.C., Winkler M.L., and Stern J.L. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 166 (1988) 623-631
15. Subak L.L., Hricak H., Powell C.B., Azizi L., and Stern J.L. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 86 (1995) 43-50
16. Scheidler J., Hricak H., Yu K.K., Subak L., and Segal M.R. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 278 (1997) 1096-1101
17. Khoo V.S., Dearnaley D.P., Finnigan D.J., Padhani A., Tanner S.F., and Leach M.O. Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. Radiother Oncol 42 (1997) 1-15
18. Petersch B., Bogner J., Fransson A., Lorang T., and Pötter R. Effects of geometric distortion in 0.2T MRI on radiotherapy treatment planning of prostate cancer. Radiother Oncol 71 (2004) 55-64
19. Fransson A., Andreo P., and Pötter R. Aspects of MR image distortions in radiotherapy treatment planning. Strahlenther Onkol 177 (2001) 59-73
20. Dimopoulos J., Schard G., Berger D., et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, patho-anatomical structures and organs at risk. Int J Radiat Oncol Biol Phys 64 (2006) 1380-1388
21. Rose P.G., Adler L.P., Rodriguez M., Faulhaber P.F., Abdul-Karim F.W., and Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 17 (1999) 41-45
22. Reinhardt M.J., Ehritt-Braun C., Vogelgesang D., et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 218 (2001) 776-782
23. Xue F., Lin L.L., Dehdashti F., Miller T.R., Siegel B.A., and Grigsby P.W. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol 101 (2006) 147-151
24. Lin L.L., Yang Z., Mutic S., Miller T.R., and Grigsby P.W. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. Int J Radiat Oncol Biol Phys 65 (2006) 177-181
25. Mutic S., Grigsby P.W., Low D.A., et al. PET-guided three-dimensional treatment planning of intracavitary gynecologic implants. Int J Radiat Oncol Biol Phys 52 (2002) 1104-1110
26. Malyapa R.S., Mutic S., Low D.A., et al. Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1140-1146
27. Grigsby P.W., Malyapa R.S., Higashikubo R., et al. Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix. Mol Imaging Biol 9 (2007) 278-283
28. Ling C.C., Schell M.C., Working K.R., et al. CT-assisted assessment of bladder and rectum dose in gynecological implants. Int J Radiat Oncol Biol Phys 13 (1987) 1577-1582
29. Pötter R., Kovacs G., Lenzen B., Prott F.J., Knocke T.H., and Haverkamp U. Technique of MRI assisted brachytherapy treatment planning. Activity J 5 (1991) 145-148
30. Schoeppel S.L., Ellis J.H., LaVigne M.L., Schea R.A., and Roberts J.A. Magnetic resonance imaging during intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 23 (1992) 169-174
31. Tardivon A.A., Kinkel K., Lartigau E., Masselot J., Gerbaulet A.P., and Vanel D. MR imaging during intracavitary brachytherapy of vaginal and cervical cancer: preliminary results. Radiographics 16 (1996) 1363-1370
32. Datta N.R., Srivastava A., Maria Das K.J., Gupta A., and Rastogi N. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer. Brachytherapy 5 (2006) 223-229
33. Kim R.Y., and Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms. Brachytherapy 2 (2003) 200-206
34. Schoeppel S.L., LaVigne M.L., Martel M.K., et al. Three-dimensional treatment planning of intracavitary gynecologic implants: analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 28 (1993) 277-283
35. Nag S., Cardenes H., Chang S., et al., Image-guided Brachytherapy Working Group. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys 60 (2004) 1160-1172
36. Nag S. Controversies and new developments in gynecologic brachytherapy: image-based intracavitary brachytherapy for cervical carcinoma. Semin Radiat Oncol 16 (2006) 164-167
37. Kirisits C., Lang S., Dimopoulos J., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning and dosimetric results. Int J Radiat Oncol Biol Phys 65 (2006) 624-630
38. Dimopoulos J., Kirisits C., Petric P., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 66 (2006) 83-90
39. Wachter-Gerstner N., Wachter S., Reinstadler E., et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 68 (2003) 269-276
40. Berger D., Dimopoulos J., Georg P., et al. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. Int J Radiat Oncol Biol Phys 67 (2007) 1451-1459
41. Koom W.S., Sohn D.K., Kim J.Y., et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys 68 (2007) 1446-1454
42. Georg P., Kirisits C., Hammer J., et al. Correlation of dose volume parameters, rectoscopy findings and rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Brachytherapy 5 (2006) 81
43. Dimopoulos J., Georg P., Kirisits K., Lang S., Berger D., and Pötter R. The predictive value of dose volume parameters on local tumour control in MRI assisted brachytherapy of cervix cancer. Radiother Oncol 81 S1 (2006) S39
44. Brooks S., Bownes P., Lowe G., Bryant L., and Hoskin P.J. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. Int J Radiat Oncol Biol Phys 63 (2005) 934-939
45. Kirisits C., Pötter R., Lang S., et al. Dose and volume parameters for MRI based treatment planning in intracavitary brachytherapy of cervix cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
46. Hellebust T.P., Tanderup K., Bergstrand E.S., Knutsen B.H., Røislien J., and Olsen D.R. Reconstruction of a ring applicator using CT imaging: impact of the reconstruction method and applicator orientation. Phys Med Biol 52 (2007) 4893-4904
47. Fellner C., Pötter R., Knocke T.H., et al. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 58 (2001) 53-62
48. Pelloski C.E., Palmer M., Chronowski G.M., et al. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 131-137
49. Pötter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 83 (2007) 148-155
50. Wachter-Gerstner N., Wachter S., Reinstadler E., et al. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol 68 (2003) 51-59
51. Lang S., Kirisits C., Dimopoulos J., et al. Treatment planning for MRI assisted brachytherapy of gynaecological malignancies based on total dose constraints. Int J Radiat Oncol Biol Phys 69 (2007) 619-627
52. Pötter R., Dimopoulos J., Bachtiary B., et al. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up. Radiother Oncol 79 (2006) 80-86